drugset / Trial / NCT00398008
HIV Risk Reduction and Drug Abuse Treatment in Iran
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomized, double blind clinical trial comparing buprenorphine and naltrexone maintenance treatment when combined with drug abuse and HIV risk reduction counseling (DC-HIV) for heroin and opium addicts in Iran.
Timeline
- Start
- 2004-10
- Primary completion
- 2006-12
- Completion
- 2008-12
Outcome
Outcome not reported
Stopped: “Study was never able to start in IRAN”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |
| Subject | Naltrexone | Small molecule | — | — |